GSK PLC group: subsidiaries and structure
Public Limited Company (PLC) · LONDON, United Kingdom · LEI 5493000HZTVUYLO1D793
55subsidiaries
16countries
35held directly
13lapsed LEIs
19links on accounts older than 24 months
926ISINs of subsidiaries
Summary
GSK PLC is the ultimate parent of 55 subsidiaries with LEIs in 16 countries, as reported to GLEIF. 35 are held directly; the others sit below intermediate companies. The largest numbers are in the United Kingdom (28), in Canada (4) and in Germany (3). 13 of the subsidiaries have a lapsed LEI, and 19 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 3 ISINs for the parent and 926 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
and 1 more
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
19 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
جي إس كيه لايف ساينسز م م ح United Arab Emirates
GLAXOSMITHKLINE BIOLOGICALS Belgium
14245563 CANADA INC. Canada
BELLUS HEALTH INC. Canada
GLAXOSMITHKLINE GMBH & CO. KG Germany
GSK VACCINES GMBH Germany
GLAXO WELLCOME SA Spain
GLAXO WELLCOME PRODUCTION France
GLAXOSMITHKLINE BIOLOGICALS France
GLAXO GROUP LIMITED United Kingdom
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED United Kingdom
GLAXO OPERATIONS UK LIMITED United Kingdom
GLAXO WELLCOME UK LIMITED United Kingdom
GLAXOSMITHKLINE FINANCE PLC United Kingdom
GLAXOSMITHKLINE CAPITAL PLC United Kingdom
GLAXOSMITHKLINE IHC LIMITED United Kingdom
GSK CAPITAL B.V. United Kingdom
SETFIRST LIMITED United Kingdom
SMITHKLINE BEECHAM LEGACY H LIMITED United Kingdom
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED United Kingdom
GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED United Kingdom
GLAXOSMITHKLINE SERVICES UNLIMITED United Kingdom
VIIV HEALTHCARE FINANCE LIMITED United Kingdom
VIIV HEALTHCARE LIMITED United Kingdom
VIIV HEALTHCARE UK (NO.3) LIMITED United Kingdom
VIIV HEALTHCARE UK LIMITED United Kingdom
WELLCOME LIMITED United Kingdom
GLAXOSMITHKLINE LIMITED Hong Kong
BIDDLE SAWYER LIMITED India
CORIXA CORPORATION United States
GLAXOSMITHKLINE CAPITAL INC. United States
GLAXOSMITHKLINE LLC United States
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| جي إس كيه لايف ساينسز م م ح | United Arab Emirates | DUBAI | 2138002S2JSG8ISGA857 | 2024 | > 24 months |
| GLAXOSMITHKLINE BIOLOGICALS | Belgium | RIXENSART | 5493004ZNHN6CAC59L18 | 2024 | |
| GLAXOSMITHKLINE INSURANCE LTD. | Bermuda | Hamilton | 549300JQ1QQ2ZDEO3R05 | 2021 | lapsed > 24 months |
| 14245563 CANADA INC. | Canada | MONTREAL | 21380062J7EQ864B8S84 | 2023 | > 24 months |
| BELLUS HEALTH INC. | Canada | MONTREAL | 213800PSAL919X9LT792 | 2023 | > 24 months |
| ID BIOMEDICAL CORPORATION OF QUEBEC | Canada | QUÉBEC | 213800B6ED44TX9J9Z71 | 2025 | |
| VIIV HEALTHCARE ULC | Canada | CALGARY | 5493005GM7MZ6Z56NQ05 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE PHARMACEUTICALS COSTA RICA SOCIEDAD ANONIMA | Costa Rica | SAN DIEGO | 984500CEWBF37ADF8F42 | 2024 | |
| GLAXOSMITHKLINE GMBH & CO. KG | Germany | MUNICH | 549300SXMWE9AHMZRC98 | 2024 | |
| GSK VACCINES GMBH | Germany | MARBURG | 2138001HN9OYGAMHM860 | 2024 | |
| SMITHKLINE BEECHAM PHARMA GMBH & CO. KG | Germany | MUNCEHN | 213800HVRIIUY19ZYZ41 | 2024 | |
| GLAXO WELLCOME SA | Spain | ARANDA DE DUERO | 213800EBKTZQ5P2TN559 | 2024 | |
| GLAXO WELLCOME PRODUCTION | France | RUEIL-MALMAISON | 213800YFBI7VE3TIBM85 | 2024 | |
| GLAXOSMITHKLINE BIOLOGICALS | France | SAINT-AMAND LES EAUX | 213800NQEFE4U61TAB32 | 2024 | |
| BURROUGHS WELLCOME INTERNATIONAL LIMITED | United Kingdom | BRENTFORD | 5493007KLUDIEIL2GR34 | 2021 | lapsed > 24 months |
| ESKAYLAB LIMITED | United Kingdom | BRENTFORD | 5493008QEMJCWRW62058 | 2021 | lapsed > 24 months |
| GLAXO GROUP LIMITED | United Kingdom | STEVENAGE | 5493006TSD23CIX01B10 | 2025 | |
| GLAXO OPERATIONS UK LIMITED | United Kingdom | LONDON | 2138005GK52LHBCLIF36 | 2024 | |
| GLAXO WELLCOME UK LIMITED | United Kingdom | STEVENAGE | 213800H7QV93VB5S3154 | 2024 | |
| GLAXOSMITHKLINE CAPITAL PLC | United Kingdom | LONDON | 549300U0LV41VX7LEP38 | 2024 | |
| GLAXOSMITHKLINE EXPORT LIMITED | United Kingdom | BRENTFORD | 549300VTA6UMYQE6UB22 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE FINANCE PLC | United Kingdom | LONDON | 54930086XQKV1JUFNE19 | 2025 | |
| GLAXOSMITHKLINE HOLDINGS LIMITED | United Kingdom | BRENTFORD | 549300F8TAHNC6097328 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE IHC LIMITED | United Kingdom | LONDON | 2138001OC94F4G3MHP36 | 2024 | |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED | United Kingdom | BRENTFORD | 549300BBV8QORU8WX093 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED | United Kingdom | STEVENAGE | 5493009HTKVB0TC78D91 | 2025 | |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED | United Kingdom | STEVENAGE | 213800CRQITWKFMAER64 | 2024 | |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED | United Kingdom | BRENTFORD | 5493003KPICP2R6N1G28 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED | United Kingdom | BRENTFORD | 549300X3MLVYJEQN4J15 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED | United Kingdom | BRENTFORD | 5493003QN1IPYBD6WC49 | 2021 | lapsed > 24 months |
| GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED | United Kingdom | LONDON | 5493003EJXH8XA8L9095 | 2025 | |
| GLAXOSMITHKLINE SERVICES UNLIMITED | United Kingdom | LONDON | 549300QH465T0AATXR10 | 2024 | |
| GSK CAPITAL B.V. | United Kingdom | LONDON | 549300ZGXDBU2ZV6RP76 | 2024 | |
| SETFIRST LIMITED | United Kingdom | LONDON | 549300TUPSIH7NLZWQ91 | 2024 | |
| SMITHKLINE BEECHAM LEGACY H LIMITED | United Kingdom | LONDON | 549300SCICGP1NZHZ225 | 2024 | |
| SMITHKLINE BEECHAM OVERSEAS LIMITED | United Kingdom | BRENTFORD | 549300TZ7K0VUJ6OQD26 | 2021 | lapsed > 24 months |
| VIIV HEALTHCARE FINANCE LIMITED | United Kingdom | LONDON | 549300HC7CVNGP5FSO93 | 2024 | |
| VIIV HEALTHCARE LIMITED | United Kingdom | STEVENAGE | 213800PCGWGORUQKMI06 | 2024 | |
| VIIV HEALTHCARE TRADING SERVICES UK LIMITED | United Kingdom | BRENTFORD | 54930080TNVU655ZMZ56 | 2021 | lapsed > 24 months |
| VIIV HEALTHCARE UK (NO.3) LIMITED | United Kingdom | STEVENAGE | 213800BNTNWVEP4FU828 | 2024 | |
| VIIV HEALTHCARE UK LIMITED | United Kingdom | LONDON | 213800K11T9CS8QF8L68 | 2024 | |
| WELLCOME LIMITED | United Kingdom | LONDON | 213800TQ6UUCTRJP8N60 | 2024 | |
| GLAXOSMITHKLINE LIMITED | Hong Kong | KOWLOON | 21380028VTDD9OWOZQ30 | 2023 | > 24 months |
| GLAXOSMITHKLINE BIOLOGICALS GYÓGYSZERGYÁRTÓ ÉS FORGALMAZÓ KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG | Hungary | GÖDÖLLO | 213800GGK4C8T7YBPE43 | 2025 | |
| GLAXOSMITHKLINE TRADING SERVICES LIMITED | Ireland | DUBLIN | 549300LUUARXC1IWCI61 | 2025 | |
| SMITHKLINE BEECHAM (CORK) LIMITED | Ireland | DUBLIN | 549300HZWFXYDEEPO255 | 2025 | |
| STIEFEL LABORATORIES LEGACY (IRELAND) LIMITED | Ireland | CORK | 2138008PMGGC7WN2QO54 | 2025 | |
| BIDDLE SAWYER LIMITED | India | MUMBAI | 335800AHVU9SWXODFQ28 | 2022 | > 24 months |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | India | MUMBAI | 3358002TNSC1U2DWNY52 | 2024 | > 24 months |
| GLAXOSMITHKLINE MANUFACTURING S.P.A. | Italy | VERONA | 2138006Z1PLMDSUWYG27 | 2024 | |
| GLAXOSMITHKLINE VACCINES S.R.L. | Italy | SIENA | 213800LZXCBY7XIH5O47 | 2024 | |
| ジーエスケイキャピタル | Japan | MINATO KU | 549300ZXT299F4J0SP89 | 2023 | lapsed > 24 months |
| CORIXA CORPORATION | United States | WILMINGTON | 213800EJ1YOXYD7JF760 | 2024 | |
| GLAXOSMITHKLINE CAPITAL INC. | United States | WILMINGTON | 5493007Q8VD7Q3ZYZS59 | 2024 | |
| GLAXOSMITHKLINE LLC | United States | WILMINGTON | 549300Y2PZWSSLJYI255 | 2025 |